Tracking TB Treatment Results and Side Effects
Part of Infections clinical trials.
This study follows patients being treated for tuberculosis with standard medications to see how well the treatment works and what side effects occur. Your medical records and check-ups help doctors understand which treatments are most effective.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Confirmed tuberculosis diagnosis (confirmed by lab test or tissue sample)
- Currently receiving or recently completed standard TB medication treatment
- Complete medical records and at least one full course of TB treatment documented
- Liver function tests not severely abnormal (ALT/AST not more than 2× normal)
- No serious heart conditions or liver diseases like hepatitis B or C
- Not pregnant, breastfeeding, or living with HIV
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how common TB medicines are absorbed, used, and cleared in children who are already taking treatment for tuberculosis. It may help doctors choose safer and more effective doses for children.
This study tests personalized TB treatment schedules based on your individual risk factors. Researchers want to see if matching treatment intensity to your specific situation helps cure TB while minimizing side effects.
This study looks at immune system blood tests in adults being treated for active tuberculosis and/or latent tuberculosis infection. The goal is to see if these “immune biomarkers” can help guide or improve tuberculosis management.
This study tests new, faster ways to diagnose tuberculosis (TB) using samples like sputum (mucus from your lungs), tongue swabs, and urine. It aims to see if these new tests can find TB more accurately than current methods, which could help you get the right treatment sooner.
This study looks for people who have recently completed standard treatment for drug-sensitive TB. Researchers want to check if certain tests can predict long-term health outcomes after treatment.
This study follows people with suspected or confirmed tuberculosis (TB), whether they have inactive “latent” TB or active TB. It helps researchers better understand TB’s natural course and may improve future testing and care by allowing collection and storage of samples.
Hear when a new Therapeutic Drug Monitoring (TDM) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.